Annual Total Long Term Liabilities
$343.00 K
-$849.20 K-71.23%
December 31, 2022
Summary
- As of February 10, 2025, ADMP annual total long term liabilities is $343.00 thousand, with the most recent change of -$849.20 thousand (-71.23%) on December 31, 2022.
- During the last 3 years, ADMP annual total long term liabilities has fallen by -$5.09 million (-93.68%).
Performance
ADMP Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Long Term Liabilities
$1.57 M
-$4.24 M-73.02%
June 30, 2023
Summary
- As of February 10, 2025, ADMP quarterly total long term liabilities is $1.57 million, with the most recent change of -$4.24 million (-73.02%) on June 30, 2023.
- Over the past year, ADMP quarterly long term liabilities has increased by +$639.30 thousand (+68.89%).
Performance
ADMP Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
ADMP Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -71.2% | +68.9% |
| 3 y3 years | -93.7% | -62.8% |
| 5 y5 years | -88.8% | -44.4% |
ADMP Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -71.2% | at low | -73.0% | -78.1% |
| 5 y | 5-year | -95.4% | at low | -78.9% | -78.1% |
| alltime | all time | -97.8% | -129.2% | -90.0% | -112.8% |
Adamis Pharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $1.57 M(-73.0%) |
| Mar 2023 | - | $5.81 M(+1593.7%) |
| Dec 2022 | $343.00 K(-71.2%) | $343.00 K(-17.9%) |
| Sep 2022 | - | $417.70 K(-55.0%) |
| Jun 2022 | - | $928.00 K(-12.9%) |
| Mar 2022 | - | $1.07 M(-10.6%) |
| Dec 2021 | $1.19 M(-84.0%) | $1.19 M(-15.4%) |
| Sep 2021 | - | $1.41 M(-60.6%) |
| Jun 2021 | - | $3.58 M(-13.8%) |
| Mar 2021 | - | $4.15 M(-44.3%) |
| Dec 2020 | $7.44 M(+37.1%) | $7.44 M(+110.2%) |
| Sep 2020 | - | $3.54 M(-16.0%) |
| Jun 2020 | - | $4.22 M(+185.5%) |
| Mar 2020 | - | $1.48 M(-72.8%) |
| Dec 2019 | $5.43 M(+4726.2%) | $5.43 M(+218.1%) |
| Sep 2019 | - | $1.71 M(-6.1%) |
| Jun 2019 | - | $1.82 M(+22.3%) |
| Mar 2019 | - | $1.49 M(+1221.2%) |
| Dec 2018 | $112.50 K(-96.3%) | $112.50 K(-78.3%) |
| Sep 2018 | - | $519.00 K(-81.6%) |
| Jun 2018 | - | $2.82 M(-4.2%) |
| Mar 2018 | - | $2.94 M(-4.0%) |
| Dec 2017 | $3.07 M(-21.2%) | $3.07 M(-13.2%) |
| Sep 2017 | - | $3.53 M(-3.3%) |
| Jun 2017 | - | $3.66 M(-3.2%) |
| Mar 2017 | - | $3.78 M(-3.1%) |
| Dec 2016 | $3.90 M(>+9900.0%) | $3.90 M(+22.3%) |
| Sep 2016 | - | $3.19 M(>+9900.0%) |
| Jun 2016 | - | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2015 | - | $0.00(0.0%) |
| Jun 2015 | - | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) |
| Dec 2014 | $0.00(0.0%) | - |
| Sep 2014 | - | $0.00(0.0%) |
| Jun 2014 | - | $0.00(0.0%) |
| Mar 2014 | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2013 | - | $0.00(0.0%) |
| Sep 2013 | - | $0.00(0.0%) |
| Jun 2013 | - | $0.00(0.0%) |
| Mar 2013 | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2012 | - | $0.00(0.0%) |
| Sep 2012 | - | $0.00(0.0%) |
| Jun 2012 | - | $0.00(0.0%) |
| Mar 2012 | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2011 | - | $0.00(0.0%) |
| Sep 2011 | - | $0.00(0.0%) |
| Jun 2011 | - | $0.00(0.0%) |
| Mar 2011 | $0.00 | $0.00(0.0%) |
| Dec 2010 | - | $0.00(0.0%) |
| Sep 2010 | - | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2010 | - | $0.00(0.0%) |
| Mar 2010 | $0.00(-100.0%) | $0.00(0.0%) |
| Dec 2009 | - | $0.00(0.0%) |
| Sep 2009 | - | $0.00(0.0%) |
| Jun 2009 | - | $0.00(-100.0%) |
| Mar 2009 | - | $778.00 K(+0.0%) |
| Dec 2008 | $777.90 K(+53.4%) | $777.90 K(+8.9%) |
| Sep 2008 | - | $714.00 K(+12.1%) |
| Jun 2008 | - | $637.00 K(+12.0%) |
| Mar 2008 | - | $569.00 K(+12.2%) |
| Dec 2007 | $507.10 K(+55.5%) | $507.10 K(+11.5%) |
| Sep 2007 | - | $455.00 K(+10.7%) |
| Jun 2007 | - | $411.00 K(+10.8%) |
| Mar 2007 | - | $371.00 K(+13.8%) |
| Dec 2006 | $326.10 K(-90.8%) | $326.10 K(-90.3%) |
| Sep 2006 | - | $3.37 M(-0.3%) |
| Jun 2006 | - | $3.38 M(-4.7%) |
| Mar 2006 | - | $3.55 M(+0.4%) |
| Dec 2005 | $3.53 M(-76.4%) | $3.53 M(+53.3%) |
| Sep 2005 | - | $2.31 M(-67.0%) |
| Jun 2005 | - | $6.99 M(+6.3%) |
| Mar 2005 | - | $6.57 M(-56.2%) |
| Dec 2004 | $14.99 M(+6.6%) | $14.99 M(>+9900.0%) |
| Sep 2004 | - | $0.00(-100.0%) |
| Jun 2004 | - | $14.21 M(-2.1%) |
| Mar 2004 | - | $14.51 M(+3.2%) |
| Dec 2003 | $14.06 M(-10.5%) | $14.06 M(-1.4%) |
| Sep 2003 | - | $14.26 M(-1.5%) |
| Jun 2003 | - | $14.47 M(-1.4%) |
| Mar 2003 | - | $14.68 M(-6.6%) |
| Dec 2002 | $15.72 M(+3142.0%) | $15.72 M(+2945.9%) |
| Sep 2002 | - | $516.00 K(-74.0%) |
| Jun 2002 | - | $1.99 M(+43.5%) |
| Mar 2002 | - | $1.38 M(+185.5%) |
| Dec 2001 | $484.80 K(+45.2%) | $484.80 K(+27.6%) |
| Sep 2001 | - | $380.00 K(+31.9%) |
| Jun 2001 | - | $288.00 K(-47.1%) |
| Mar 2001 | - | $544.00 K(+62.9%) |
| Dec 2000 | $333.90 K(-89.2%) | $333.90 K(-82.5%) |
| Sep 2000 | - | $1.90 M(-18.2%) |
| Jun 2000 | - | $2.33 M(-3.5%) |
| Mar 2000 | - | $2.41 M(-22.2%) |
| Dec 1999 | $3.10 M(+6.9%) | $3.10 M(-6.0%) |
| Sep 1999 | - | $3.30 M(-10.8%) |
| Jun 1999 | - | $3.70 M(+27.6%) |
| Mar 1999 | - | $2.90 M(0.0%) |
| Dec 1998 | $2.90 M(-3000.0%) | $2.90 M(-3000.0%) |
| Sep 1998 | - | -$100.00 K(0.0%) |
| Dec 1997 | -$100.00 K | -$100.00 K(-50.0%) |
| Jun 1997 | - | -$200.00 K(+100.0%) |
| Jun 1996 | - | -$100.00 K(0.0%) |
| Jun 1995 | - | -$100.00 K |
FAQ
- What is Adamis Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Adamis Pharmaceuticals?
- What is Adamis Pharmaceuticals annual total long term liabilities year-on-year change?
- What is Adamis Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Adamis Pharmaceuticals?
- What is Adamis Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Adamis Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of ADMP is $343.00 K
What is the all time high annual total long term liabilities for Adamis Pharmaceuticals?
Adamis Pharmaceuticals all-time high annual total long term liabilities is $15.72 M
What is Adamis Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, ADMP annual total long term liabilities has changed by -$849.20 K (-71.23%)
What is Adamis Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of ADMP is $1.57 M
What is the all time high quarterly long term liabilities for Adamis Pharmaceuticals?
Adamis Pharmaceuticals all-time high quarterly total long term liabilities is $15.72 M
What is Adamis Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, ADMP quarterly total long term liabilities has changed by +$639.30 K (+68.89%)